Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets

Gault, 2010, An overview of sphingolipid metabolism: from synthesis to breakdown, Adv Exp Med Biol, 688, 1, 10.1007/978-1-4419-6741-1_1 Riboni, 1997, The role of sphingolipids in the process of signal transduction, Prog Lipid Res, 36, 153, 10.1016/S0163-7827(97)00008-8 Bartke, 2009, Bioactive sphingolipids. Metabolism and function, J Lipid Res, 50, S91, 10.1194/jlr.R800080-JLR200 Gangoiti, 2010, Control of metabolism and signaling of simple bioactive sphingolipids: implications in disease, Prog Lipid Res, 49, 316, 10.1016/j.plipres.2010.02.004 Huwiler, 2000, Physiology and pathophysiology of sphingolipid metabolism and signaling, Biochim Biophys Acta, 1485, 63, 10.1016/S1388-1981(00)00042-1 Karliner, 2013, Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress, Biochim Biophys Acta, 1831, 203, 10.1016/j.bbalip.2012.06.006 Bode, 2010, Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate, J Cell Biochem, 109, 1232 Dahm, 2006, Distribution and dynamic changes of sphingolipids in blood in response to platelet activation, J Thromb Haemost, 4, 2704, 10.1111/j.1538-7836.2006.02241.x Hänel, 2007, Erythrocytes store and release sphingosine 1-phosphate in blood, FASEB J, 21, 1202, 10.1096/fj.06-7433com Ito, 2007, Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes, Biochem Biophys Res Commun, 357, 212, 10.1016/j.bbrc.2007.03.123 Knapp, 2012, Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat, Basic Res Cardiol, 107, 294, 10.1007/s00395-012-0294-0 Yatomi, 1997, Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum, J Biochem, 121, 969, 10.1093/oxfordjournals.jbchem.a021681 Pappu, 2007, Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate, Science, 316, 295, 10.1126/science.1139221 Takabe, 2008, “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets, Pharmacol Rev, 60, 181, 10.1124/pr.107.07113 Kim, 2009, Export and functions of sphingosine-1-phosphate, Biochim Biophys Acta, 1791, 692, 10.1016/j.bbalip.2009.02.011 Yatomi, 1995, Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets, Blood, 86, 193, 10.1182/blood.V86.1.193.bloodjournal861193 Venkataraman, 2008, Vascular endothelium as a contributor of plasma sphingosine 1-phosphate, Circ Res, 102, 669, 10.1161/CIRCRESAHA.107.165845 Yang, 2009, Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome, Am J Physiol Endocrinol Metab, 297, E211, 10.1152/ajpendo.91014.2008 Hojjati, 2005, Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice, J Biol Chem, 280, 10284, 10.1074/jbc.M412348200 Hojjati, 2005, Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice, Biochim Biophys Acta, 1737, 44, 10.1016/j.bbalip.2005.08.006 Watt, 2012, Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide, Diabetologia, 55, 2741, 10.1007/s00125-012-2649-3 Serlie, 2007, Short-term manipulation of plasma free fatty acids not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects, J Clin Endocrinol Metab, 92, 1524, 10.1210/jc.2006-2347 Nawrocki, 2004, Effect of plasma free fatty acid concentration on the content and composition of the free fatty acid fraction in rat skeletal muscles, Horm Metab Res, 36, 601, 10.1055/s-2004-825922 Blachnio-Zabielska, 2012, A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans, Rapid Commun Mass Spectrom, 26, 1134, 10.1002/rcm.6216 Awojoodu, 2014, Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflamatory microparticle generation in SCD, Blood, 124, 1941, 10.1182/blood-2014-01-543652 Xu, 2010, Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes, FASEB J, 24, 2507, 10.1096/fj.09-153635 Yang, 1999, Metabolism and functional effects of sphingolipids in blood cells, Br J Haematol, 107, 282, 10.1046/j.1365-2141.1999.01697.x Tani, 2005, Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets, J Lipid Res, 46, 2458, 10.1194/jlr.M500268-JLR200 Simon, 1998, Sphingomyelinase activity in human platelets, Thromb Res, 90, 155, 10.1016/S0049-3848(98)00033-4 Tani, 2007, Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space, Cell Signal, 19, 229, 10.1016/j.cellsig.2006.07.001 31 Yatomi, 1997, Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid, J Biol Chem, 272, 5291, 10.1074/jbc.272.8.5291 Kurek, 2014, Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease, Liver Int, 34, 1074, 10.1111/liv.12331 Kolter, 2011, A view on sphingolipids and disease, Chem Phys Lipids, 164, 590, 10.1016/j.chemphyslip.2011.04.013 Hornemann, 2013, Sphingolipids and atherosclerosis, Atherosclerosis, 226, 16, 10.1016/j.atherosclerosis.2012.08.041 Strub, 2010, Extracellular and intracellular action of sphingosine-1-phosphate, Adv Exp Med Biol, 688, 141, 10.1007/978-1-4419-6741-1_10